AVIA Vascular Enables Vascular Preservation With Innovative Solutions

SALT LAKE CITY, UT / ACCESSWIRE / July 10, 2024 / AVIA Vascular, a pioneering force in the healthcare technology industry, is proud to announce its strategic positioning as a leader in vessel preserving technologies within the vascular access space. With the successful adoption of its current product, The ALLY™ device, AVIA Vascular is revolutionizing phlebotomy and significantly enhancing the patient and provider experience.

The ALLY device is setting a new standard in blood collection by removing the needle from the procedure. Its innovative design and functionality can dramatically improve the patient experience by reducing discomfort, minimizing harms, and preventing the need for excess venipunctures. Providers are equally benefiting from the device’s safety and ease of use, which can streamline the process and reduce the occurrence of repeat attempts and needlestick injuries.

Building on the success of The ALLY device, AVIA Vascular is thrilled to introduce its newest patented product, The Stiletto®. This cutting-edge device supports AVIA Vascular’s efforts to reduce the use of needles in healthcare, preventing clinical harms and economic implications associated with needlesticks. The Stiletto is designed with unique technology intended to prevent premature catheter failure, making it an indispensable tool for healthcare providers and a game-changer for patient care.

“Our commitment to innovation and excellence in vascular preservation is unwavering,” said Kevin Cook, CEO of AVIA Health. “The introduction of The Stiletto underscores our dedication to improving healthcare outcomes by providing the best tools for both patients and providers. We believe this new device will cement our position as an industry leader and set a new benchmark for quality and performance in vascular care.”

With growing demand for more efficient and effective vascular access solutions, AVIA Vascular remains at the forefront with a focus on vascular preservation. The company’s devotion to research, development, and customer satisfaction ensures that it delivers products that meet the highest standards of care. “We are committed to ensuring that the relationship with patients and providers is a positive one,” says Cook.

For more information about AVIA Health, The ALLY device, and The Stiletto, please visit www.avia-vascular.com.

About AVIA Vascular

AVIA Vascular is dedicated to advancing healthcare through innovative solutions in the vascular access space. Our mission is to enhance patient care and provider efficiency with progressive technology and exceptional product design. With a commitment to quality and excellence, AVIA Vascular is transforming vascular care.

Contact Information

Kainoa Clark
Chief Marketing Officer
kainoa.clark@netwasatch.com
801-473-2119

SOURCE: AVIA Vascular

View the original press release on newswire.com.

View the original press release on accesswire.com

Staff

Recent Posts

Is SynergyRx GLP-1 Legitimate? Platform Lists Compounded Semaglutide at $200 With Oral Tablet Options

Telehealth Provider Offers FDA-Approved and Compounded Weight Loss Medications in All 50 States, Subject to…

4 hours ago

Direct Meds GLP-1 Medications Platform Maintains LegitScript Certification as New Year Weight Loss Interest Peaks Amid Compounding Regulatory Shifts

Telehealth Platform Facilitates Compounded Semaglutide and Tirzepatide Access Through Licensed Provider Evaluation as FDA Shortage…

4 hours ago

Best Peptides for Boosting Growth Hormone: ReadyRx Lists Prescription Sermorelin in Injectable and Needle-Free Formats for 2026

Analysis examines best peptides for boosting growth hormone as ReadyRx lists prescription sermorelin in injectable…

4 hours ago

Best Fat Burner For Men 2026: Effective Fat Burning Supplements For Men’s Belly Fat Launched By Wolfson Brands Ltd

Discover the best fat burner for men in 2025. Explore Wolfson Brand’s effective fat-burning supplements…

4 hours ago

MEDIROM Partners with World

Deploying “Proof of Human” Infrastructure throughout Japan, a Technology Envisioned by Sam Altman and Alex…

4 hours ago